Botulinum toxin type A for Cold Intolerance

"According to the trial's qualification standards, suitable candidates must be aged between 18 and 75. Simultaneously, 6 trials are being conducted for participants under 18 years old while 57 study programs target those older than 65."

"Evident on clinicaltrials.gov, this investigation is not accepting any further participants at the present moment; it was initially posted June 2nd of 2021 and most recently updated August 22nd 2022. Although applicants are no longer needed for this trial, there are currently 62 other medical studies that require enrolment."

"Botox is well known for its ability to treat urinary incontinence. Additionally, it may be prescribed by doctors as a form of intervention for spinal cord dysfunction and overactive bladder syndrome (OABs)."

"As of now, 61 clinical trials utilizing Botox are underway with 20 in their final phase. Most studies related to this medication are based out of Farmington Hills, Michigan but there exist 754 other research sites conducting experiments involving the drug."

"This trial has since concluded its recruitment stage. It was first posted on June 2nd 2021 and most recently updated on August 22nd 2022. For those still seeking to participate in a similar study, there is one active clinical trial for cold intolerance and 61 studies recruiting participants for Botox treatments."

"To enroll in this medical experiment, participants must be between 18 to 75 years old and demonstrate cold intolerance. This clinical trial is expected to admit 28 individuals in total."

"Limited trials have been conducted in the past to assess Botox's safety and efficacy, thus it was assigned a score of 1."